相关实验视频

Updated: Jun 28, 2025

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

对分散型大B细胞淋巴瘤的第一线治疗的新见解:我们是否在改善结果?

Pau Abrisqueta^1,2

¹Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035 Barcelona, Spain.

Journal of clinical medicine

|April 13, 2024

概括

扩散性大B细胞淋巴瘤 (DLBCL) 治疗正在发展到R-CHOP之外. 像CAR-T细胞和抗体-药物合体这样的新疗法在DLBCL患者的改善结果方面表现有前途.

科学领域:

在瘤学瘤学.
血液学血液学血液学
免疫治疗是一种免疫疗法.

背景情况:

扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的淋巴瘤亚型,患者亚组各异.
R-CHOP疗法是目前先进DLBCL的标准一线治疗方案,在60%以上的患者中实现了缓解.
过去改善R-CHOP疗效的努力取得了有限的成功.

研究的目的:

审查DLBCL最近的治疗进展.
探索新策略对初始DLBCL管理的潜在影响.

主要方法:

关于DLBCL治疗的最新进展的文献综述.
分析新兴的治疗方式,包括小分子,单克隆抗体,ADC,BsAbs和CAR T细胞疗法.

主要成果:

几种新的治疗方法在淋巴瘤治疗中显示出有前途的结果.
新兴疗法为当前DLBCL治疗模式提供了潜在的替代方案和补充.

结论:

新型疗法可能会对DLBCL的初始治疗产生重大影响.
对这些先进治疗方法的持续研究对于优化DLBCL患者的治疗结果至关重要.

关键词:

扩散大的B细胞淋巴瘤.作为一线治疗的第一线治疗.新的治疗方法

更多相关视频

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...